Abstract
Ischemia and reperfusion events within the heart and brain and similar trauma-induced ischemia/reperfusion events lead to significant morbidity and mortality. In the past two decades, an excessive innate immune response has been identified as the mediator of reperfusion-induced tissue damage. Recent evidence indicates that naturally occurring autoantibody (NAb) activation of complement is a major mechanism of injury due to ischemia/reperfusion. This chapter focuses on the antigens exposed by ischemia and recognized by NAbs, the mechanism of complement activation by damaging NAbs and the protective role of IVIG in ischemia/reperfusion-induced pathology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Annunziato L, Pignataro G, Boscia F et al. ncx1, ncx2, and ncx3 gene product expression and function in neuronal anoxia and brain ischemia. AnnN Y Acad Sci 2007; 1099:413–26. PMID: 17446481 doi: 10.1196/annals. 1387.050
Kaljusto ML, Rutkovsky A, Stenslokken KO et al. Postconditioning in mouse hearts is inhibited by blocking the reverse mode of the sodium-calcium exchanger. Interact Cardiovasc Thorac Surg 2010; 10:743–8. PMID:20139199 doi:10.1510/icvts.2009.217083
Nizet V, Johnson RS. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 2009; 9:609–17. PMID: 19704417 doi:10.1038/nri2607
Taylor CT, Cummins EP. The role of NF-kappaB in hypoxia-induced gene expression. Ann N Y Acad Sci 2009; 1177:178–84. PMID:19845620 doi: 10.1111/j.l749-6632.2009.05024.x
Zhao ZQ. Oxidative stress-elicited myocardial apoptosis during reperfusion. Curr Opin Pharmacol 2004; 4:159–65. PMID:15063360 doi: 10.1016/j.coph.2003.10.010
Shea-Donohue T, Anderson J, Swiecki C. Ischemia/reperfusion injury. In: Tsokos GC, Atkins JL, eds. Combat Medicine. Totowa, New Jersey: Humana Press; 2003:219–248.
Hernandez LA, Grisham MB, Twohig B et al. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol 1987; 253:H699–703. PMID:3631303
Sisley AC, Desai T, Harig JM et al. Neutrophil depletion attenuates human intestinal reperfusion injury. J Surg Res 1994; 57:192–6. PMID:8041137 doi: 10.1006/jsre. 1994.1130
Abonia JP, Friend DS, Austen WG Jr. et al. Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle. J Immunol 2005; 174:7285–91. PMID: 15905575
Arumugam TV, Magnus T, Woodruff TM et al. Complement mediators in ischemia-reperfusion injury. Clin Chim Acta 2006; 374:33–45. PMID:16872589 doi:10.1016/j.cca.2006.06.010
Kim SJ, Gershov D, Ma X et al. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 2002; 196:655–65. PMID: 12208880 doi:10.1084/jem.20020542
Baumgarth N, Herman OC, Jager GC et al. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000; 192:271–80. PMID:10899913 doi: 10.1084/jem. 192.2.271
Boes M. Role of natural and immune IgM antibodies in immune responses. Mol Immunol 2000; 37:1141–9. PMID:11451419 doi:10.1016/S0161-5890(01)00025-6
Avrameas S. Natural autoantibodies: from ‘horror autotoxicus’ to ‘gnothi seauton’. Immunol Today 1991; 12:154–9. PMID:1715166
Avrameas S, Ternynck T. Natural autoantibodies: the other side of the immune system. Res Immunol 1995; 146:235–48. PMID:8577986 doi: 10.1016/0923-2494(96)80259-8
Weiser MR, Williams JP, Moore FD et al. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 1996; 183:2343–8. PMID:8642343 doi:10.1084/jem.l83.5.2343
Williams JP, Pechet TT, Weiser MR et al. Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol 1999; 86:938–42. PMID:10066708
Zhang M, Michael LH, Grosjean SA et al. The role of natural IgM in myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 2006; 41:62–7. PMID: 16781728 doi:10.1016/j.yjmcc.2006.02.006
Park P, Haas M, Cunningham PN et al. Injury in renal ischemia-reperfusion is independent from immunoglobulins and T-lymphocytes. Am J Physiol Renal Physiol 2002; 282:F352–7. PMID: 11788450
Renner B, Strassheim D, Amura CR et al. B-cell subsets contribute to renal injury and renal protection after ischemia/reperfusion. J Immunol 2010; 185:4393–400. PMID:20810984 doi: 10.4049/jimmunol.0903239
Holers VM, Kulik L. Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B-cell selection and activation. Mol Immunol 2007; 44:64–72. PMID: 16876864 doi: 10.1016/j. molimm.2006.07.003
Ochsenbein AF, Zinkernagel RM. Natural antibodies and complement link innate and acquired immunity. Immunol Today 2000; 21:624–30. PMID:11114423 doi:10.1016/S0167-5699(00)01754-0
Fleming SD, Shea-Donohue T, Guthridge JM et al. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol 2002; 169:2126–33. PMID: 12165541
Reid RR, Woodcock S, Shimabukuro-Vornhagen A et al. Functional activity of natural antibody is altered in Cr2-deficient mice. J Immunol 2002; 169:5433–5440. PMID: 12421918
Woods KM, Pope MR, Hoffman SM et al. CR2+ Marginal zone B-cell production of pathogenic natural antibodies is C3 independent. J Immunol 2011.
Fleming SD, Monestier M, Tsokos GC. Accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice. J Immunol 2004; 173:4230–5. PMID: 15356174
Williams JP, Pechet TTV, Weiser MR et al. Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol 1999; 86:938–42. PMID:10066708
Zhang M, Austen WG, Chiu I et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci USA 2004; 101:3886–91. PMID:14999103 doi:10.1073/pnas.0400347101
Zhang M, Alicot EM, Chiu I et al. Identification of the target self-antigens in reperfusion injury. J Exp Med 2006; 203:141–52. PMID: 16390934 doi:10.1084/jem.20050390
Chan RK, Verna N, Afnan J et al. Attenuation of skeletal muscle reperfusion injury with intravenous 12 amino acid peptides that bind to pathogenic IgM. Surgery 2006; 139:236–43. PMID: 16455333 doi:10.1016/j.surg.2005.05.028
Haas MS, Alicot EM, Schuerpf F et al. Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction. Cardiovasc Res 2010; 87:618–27. PMID:20462867 doi:10.1093/cvr/cvq141
Kulik L, Fleming SD, Moratz C et al. Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury. J Immunol 2009; 182:5363–73. PMID:19380783 doi: 10.4049/jimmunol.0803980
Friedman P, Horkko S, Steinberg D et al. Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation. J Biol Chem 2002; 277:7010–20. PMID: 11744722 doi: 10.1074/jbc.Ml08860200
Sparkes BL, Slone EE, Roth M et al. Intestinal lipid alterations occur prior to antibody-induced prostaglandin E2 production in a mouse model of ischemia/reperfusion. Biochim Biophys Acta 2010; 1801:517–525.
Fleming SD, Egan RP, Chai C et al. Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice. J Immunol 2004; 173:7055–61. PMID: 15557203
Monestier M, Kandiah DA, Kouts S et al. Monoclonal antibodies from NZW x BXSB F1 mice to beta2 glycoprotein I and cardiolipin. Species specificity and charge-dependent binding. J Immunol 1996; 156:2631–41. PMID:8786329
Fleming SD, Pope MR, Hoffman SM et al. Domain V peptides inhibit beta2-glycoprotein I-mediated mesenteric ischemia/reperfusion-inducedtissue damage and inflammation. J Immunol 2010; 185:6168–78. PMID:20956350 doi:10.4049/jimmunol.l002520
Hörkkö S, Miller E, Dudl E et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 1996; 98:815–25. PMID:8698874 doi: 10.1172/JCI118854
Witztum JL, Horkko S. The role of oxidized LDL in atherogenesis: immunological response and anti-phospholipid antibodies. Ann NY Acad Sci 1997; 811:88–96; discussion 96-89.
Sjöberg BG, Su J, Dahlbom I et al. Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men. Atherosclerosis 2009; 203:528–32. PMID: 18809177 doi: 10.1016/j. atherosclerosis.2008.07.009
Keith MP, Moratz C, Egan R et al. Anti-ribonucleoprotein antibodies mediate enhanced lung injury following mesenteric ischemia/reperfusion in Rag-1(-/-) mice. Autoimmunity 2007; 40:208–16. PMID: 17453720 doi: 10.1080/08916930701262986
Zschörnig O, Opitz F, Muller M. Annexin A4 binding to anionic phospholipid vesicles modulated by pH and calcium. Eur Biophys J 2007; 36:415–24. PMID:17440717 doi:10.1007/s00249-007-0147-1
Balasubramanian K, Maiti SN, Schroit AJ. Recruitment of beta-2-glycoprotein 1 to cell surfaces in extrinsic and intrinsic apoptosis. Apoptosis 2005; 10:439–46. PMID:15843904 doi:10.1007/sl0495-005-0817-3
Murakami N, Elzinga M, Singh SS et al. Direct binding of myosin II to phospholipid vesicles via tail regions and phosphorylation of the heavy chains by protein kinase C. J Biol Chem 1994; 269:16082–90. PMID:8206908
Kato M, Fukuda H, Nonaka T et al. Cleavage of nonmuscle myosin heavy chain-A during apoptosis in human Jurkat T-cells. J Biochem 2005; 137:157–66. PMID:15749830 doi:10.1093/jb/mvi015
Hill JH, Ward PA. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med 1971; 133:885–900. PMID:4993831 doi:10.1084/jem.l33.4.885
Gorsuch WB, Guikema BJ, Fritzinger DC et al. Humanized cobra venom factor decreases myocardial ischemia-reperfusion injury. Mol Immunol 2009; 47:506–10. PMID:19747734 doi: 10.1016/j. molimm.2009.08.017
Hart ML, Ceonzo KA, Shaffer LA et al. Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J Immunol 2005; 174:6373–80. PMID: 15879138
Zhang M, Takahashi K, Alicot EM et al. Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. J Immunol 2006; 177:4727–34. PMID: 16982912
Chan RK, Ibrahim SI, Takahashi K et al. The differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia-reperfusion. J Immunol 2006; 177:8080–5. PMID: 17114482
Zhou W, Farrar CA, Abe K et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 2000; 105:1363–71. PMID:10811844 doi:10.1172/JCI8621
Hill J, Lindsay TF, Ortiz F et al. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol 1992; 149:1723–8. PMID: 1387151
Davis WD, Brey RL. Antiphospholipid antibodies and complement activation in patients with cerebral ischemia. Clin Exp Rheumatol 1992; 10:455–60. PMID:1458697
Pemberton M, Anderson G, Vetvicka V et al. Microvascular effects of complement blockade with soluble recombinant CRI on ischemia/reperfusion injury of skeletal muscle. J Immunol 1993; 150:5104–13. PMID:8496606
Buerke M, Murohara T, Lefer AM. Cardioprotective effects of aC1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation 1995; 91:393–402. PMID:7805243
Horstick G, Heimann A, Gotze O et al. Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion. Circulation 1997; 95:701–8. PMID:9024160
Karpel-Massler G, Fleming SD, Kirschfink M et al. Human Cl esterase inhibitor attenuates murine mesenteric ischemia/reperfusion induced local organ injury. JSurg Res 2003; 115:247–56. PMID: 14697291 doi:10.1016/S0022-4804(03)00192-6
Nielsen EW, Mollnes TE, Harlan JM et al. C1-inhibitor reduces the ischaemia-reperfusion injury of skeletal muscles in mice after aortic cross-clamping. Scand J Immunol 2002; 56:588–92. PMID: 12472670 doi: 10.1046/j. 1365-3083.2002.01173.x
Akita N, Nakase H, Kaido T et al. Protective effect of C1 esterase inhibitor on reperfusion injury in the rat middle cerebral artery occlusion model. Neurosurgery 2003; 52:395–400; discussion 400-391.
Storini C, Rossi E, Marrella V et al. C1-inhibitor protects against brain ischemia-reperfusion injury via inhibition of cell recruitment and inflammation. Neurobiol Dis 2005; 19:10–7. PMID: 15837556 doi:10.1016/j.nbd.2004.11.001
Matsushita M, Thiel S, Jensenius JC et al. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol 2000; 165:2637–42. PMID: 10946292
Nielsen EW, Waage C, Fure H et al. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement. Mol Immunol 2007; 44:1819–26. PMID: 17101176 doi: 10.1016/j.molimm.2006.10.003
De Simoni MG, Storini C, Barba M et al. Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia. J Cereb Blood Flow Metab 2003; 23:232–9. PMID: 12571454 doi: 10.1097/00004647-200302000-00010
Walsh MC, Bourcier T, Takahashi K et al. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol 2005; 175:541–6. PMID: 15972690
Moller-Kristensen M, Wang W, Ruseva M et al. Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand J Immunol 2005; 61:426–34. PMID:15882434 doi:10.1111/j.l365-3083.2005.01591.x
Arnold JN, Wormald MR, Suter DM et al. Human serum IgM glycosylation; identification of glycoforms that can bind to mannan-binding lectin. J Biol Chem 2005; 280:29080–7. PMID: 15955802 doi: 10.1074/jbc.M504528200
Roos A, Bouwman LH, Munoz J et al. Functional characterization of the lectin pathway of complement in human serum. Mol Immunol 2003; 39:655–68. PMID: 12493641 doi:10.1016/S0161-5890(02)00254-7
Busche MN, Pavlov V, Takahashi K et al. Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin. Am J Physiol Heart Circ Physiol 2009; 297:H1853–9. PMID: 19749170 doi: 10.1152/ajpheart.00049.2009
Bilgin YM, Brand A, Berger SP et al. Mannose-binding lectin is involved in multiple organ dysfunction syndrome after cardiac surgery: effects of blood transfusions. Transfusion 2008; 48:601–8. PMID: 18194386 doi: 10.1111/j. 1537-2995.2007.01585.X
Berger SP, Daha MR. Emerging role of the mannose-binding lectin-dependent pathway of complement activation in clinical organ transplantation. Curr Opin Organ Transplant 2010.
Huang Y, Qiao F, Atkinson C et al. A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury. J Immunol 2008; 181:8068–76. PMID: 19017999
Atkinson C, Song H, Lu B et al. Targeted complement inhibition by C3 d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. J Clin Invest 2005; 115:2444–53. PMID: 16127466 doi:10.1172/JCI25208
Zhang M, Carroll MC. Natural antibody mediated innate autoimmune response. Mol Immunol 2007; 44:103–10. PMID: 16876247 doi:10.1016/j.molimm.2006.06.022
Lee H, Green DJ, Lai L et al. Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury. Mol Immunol 2010; 47:972–81. PMID:20004473 doi: 10.1016/j. molimm.2009.11.022
Vani J, Elluru S, Negi VS et al. Role of natural antibodies in immune homeostasis: IVIg perspective. Autoimmun Rev 2008; 7:440–4. PMID:18558359 doi:10.1016/j.autrev.2008.04.011
Basta M. Modulation of complement-mediated immune damage by intravenous immune globulin. Clin Exp Immunol 1996; 104(Suppl l):21–5. PMID:8625538
Basta M, Dalakas MC. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest 1994; 94:1729–35. PMID:7962520 doi: 10.1172/JCI117520
Lutz HU, Stammler P, Jelezarova E et al. High doses of immunoglobulin G attenuate immune aggregate-mediated complement activation by enhancing physiologic cleavage of C3b in C3bn-IgG complexes. Blood 1996; 88:184–93. PMID:8704173
Lutz HU, Stammler P, Bianchi V et al. Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level. Blood 2004; 103:465–72. PMID:14512320 doi: 10.1182/blood-2003-05-1530
Raju R, Dalakas MC. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. Brain 2005; 128:1887–96. PMID:15857930 doi:10.1093/brain/awh518
Basta M, Van Goor F, Luccioli S et al. F(ab’)2-mediated neutralization of C3a and C5a anaphylotoxins: a novel effectorfunctionofimmunoglobulins. Nat Med 2003; 9:431–8. PMID:12612546 doi:10.1038/nm836
Anderson J, Fleming SD, Rehrig S et al. Intravenous immunoglobulin attenuates mesenteric ischemia-reperfusion injury. Clin Immunol 2005; 114:137–46. PMID:15639647 doi: 10.1016/j. clim.2004.08.018
Arumugam TV, Tang SC, Lathia JD et al. Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proc Natl Acad Sci USA 2007; 104:14104–9. PMID:17715065 doi:10.1073/pnas.0700506104
Arumugam TV, Okun E, Tang SC et al. Toll-like receptors in ischemia-reperfusion injury. Shock 2009; 32:4–16. PMID:19008778 doi:10.1097/SHK.0b013e318193e333
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Fleming, S.D. (2012). Naturally Occurring Autoantibodies Mediate Ischemia/Reperfusion-Induced Tissue Injury. In: Lutz, H.U. (eds) Naturally Occurring Antibodies (NAbs). Advances in Experimental Medicine and Biology, vol 750. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3461-0_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3461-0_13
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3460-3
Online ISBN: 978-1-4614-3461-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)